Buprenorphine solution, 100 mug/mL in methanol, ampule of 1 mL, certified reference material

Code: B-902-1ML D2-231

General description

Sold under the trade names Buprenex®, Subutex® and Suboxone®, buprenorphine is an opiate drug used to trea...


read more

Your Price
£35.64 1ML
£42.77 inc. VAT
REQUEST

General description

Sold under the trade names Buprenex®, Subutex® and Suboxone®, buprenorphine is an opiate drug used to treat opioid addiction and moderate acute pain. This Certified Spiking Solution® standard is suitable for GC/MS or LC/MS applications in forensic analysis, clinical toxicology or pharmaceutical research.

Legal Information

Buprenex is a registered trademark of Reckitt & Colman (Overseas) Ltd

CERTIFIED SPIKING SOLUTION is a registered trademark of Cerilliant Corporation

Snap-N-Spike is a registered trademark of Cerilliant Corporation

Snap-N-Shoot is a registered trademark of Cerilliant Corporation

CERILLIANT is a registered trademark of Cerilliant Corporation

Suboxone is a registered trademark of RB Pharmaceuticals Limited

Subutex is a registered trademark of RB Pharmaceuticals Limited

application(s)forensics and toxicology
concentration100 µg/mL in methanol
drug controlNarcotic Licence Schedule A (Switzerland); psicótropo (Spain); Decreto Lei 15/93: Tabela IIC (Portugal)
featureSNAP-N-SPIKE®, SNAP-N-SHOOT®
formliquid
formatsingle component solution
gradecertified reference material
InChI keyRMRJXGBAOAMLHD-IHFGGWKQSA-N
InChI1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1
manufacturer/tradenameCerilliant®
packagingampule of 1 mL
Quality Level300
SMILES stringCO[C@]12CC[C@@]3(C[C@@H]1[C@](C)(O)C(C)(C)C)[C@H]4Cc5ccc(O)c6O[C@@H]2[C@]3(CCN4CC7CC7)c56
storage temp.2-8°C
technique(s)gas chromatography (GC): suitable, liquid chromatography (LC): suitable
Cas Number52485-79-7
Hazard Class3
Un Number1230
Pack GroupII
This product has met the following criteria: